|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
Crystal structure of the non-classical mhc class ib qa-2 complexed with a self peptide
|
|
Structure:
|
 |
Qa-2 antigen. Chain: a. Fragment: extracellular alpha-1, extracellular alpha-2, extracellular alpha-3. Synonym: h-2 class i histocompatibility antigen, q7 alpha chain. Engineered: yes. Beta-2-microglobulin. Chain: b. Engineered: yes.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: q9. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Other_details: the peptide was chemically synthesized. The sequence of the peptide is naturally found in mus musculus (mouse).
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.30Å
|
R-factor:
|
0.222
|
R-free:
|
0.278
|
|
|
Authors:
|
 |
X.He,P.Tabaczewski,J.Ho,I.Stroynowski,K.C.Garcia
|
Key ref:
|
 |
X.He
et al.
(2001).
Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation.
Structure,
9,
1213-1224.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Oct-01
|
Release date:
|
19-Dec-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
9:1213-1224
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation.
|
|
X.He,
P.Tabaczewski,
J.Ho,
I.Stroynowski,
K.C.Garcia.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Qa-2 is a nonclassical MHC Ib antigen, which has been implicated in
both innate and adaptive immune responses, as well as embryonic development.
Qa-2 has an unusual peptide binding specificity in that it requires two dominant
C-terminal anchor residues and is capable of associating with a substantially
more diverse array of peptide sequences than other nonclassical MHC. RESULTS: We
have determined the crystal structure, to 2.3 A, of the Q9 gene of murine Qa-2
complexed with a self-peptide derived from the L19 ribosomal protein, which is
abundant in the pool of peptides eluted from the Q9 groove. The 9 amino acid
peptide is bound high in a shallow, hydrophobic binding groove of Q9, which is
missing a C pocket. The peptide makes few specific contacts and exhibits
extremely poor shape complementarity to the MHC groove, which facilitates the
presentation of a degenerate array of sequences. The L19 peptide is in a
centrally bulged conformation that is stabilized by intramolecular interactions
from the invariant P7 histidine anchor residue and by a hydrophobic core of
preferred secondary anchor residues that have minimal interaction with the MHC.
CONCLUSIONS: Unexpectedly, the preferred secondary peptide residues that exhibit
tenuous contact with Q9 contribute significantly to the overall stability of the
peptide-MHC complex. The structure of this complex implies a
"conformational" selection by Q9 for peptide residues that optimally
stabilize the large bulge rather than making intimate contact with the MHC
pockets.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 3.
Figure 3. Intermolecular Interactions between the L19
Peptide and Q9(a) All-atom representation of the L19 peptide
(cyan) and amino acid residues with which it interacts in the Q9
groove. The identity of Q9 residues is indicated, and the A, B,
D, E, and F pocket residues of Q9 are colored pink, orange, red,
blue, and green, respectively.(b) Two-dimensional planar
representation of the interactions between L19 and Q9 in an
orientation roughly corresponding to that shown in (a). The
peptide is colored cyan, with oxygen atoms red and nitrogen
atoms blue.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(2001,
9,
1213-1224)
copyright 2001.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.A.Swanson,
A.E.Lukacher,
and
E.Szomolanyi-Tsuda
(2009).
Immunity to polyomavirus infection: the polyomavirus-mouse model.
|
| |
Semin Cancer Biol,
19,
244-251.
|
 |
|
|
|
|
 |
P.A.Swanson,
A.R.Hofstetter,
J.J.Wilson,
and
A.E.Lukacher
(2009).
Cutting edge: shift in antigen dependence by an antiviral MHC class Ib-restricted CD8 T cell response during persistent viral infection.
|
| |
J Immunol,
182,
5198-5202.
|
 |
|
|
|
|
 |
P.A.Swanson,
C.D.Pack,
A.Hadley,
C.R.Wang,
I.Stroynowski,
P.E.Jensen,
and
A.E.Lukacher
(2008).
An MHC class Ib-restricted CD8 T cell response confers antiviral immunity.
|
| |
J Exp Med,
205,
1647-1657.
|
 |
|
|
|
|
 |
P.W.Lampton,
C.Y.Goldstein,
and
C.M.Warner
(2008).
The role of tapasin in MHC class I protein trafficking in embryos and T cells.
|
| |
J Reprod Immunol,
78,
28-39.
|
 |
|
|
|
|
 |
S.R.De Fazio,
and
C.M.Warner
(2007).
Activation of T cells by cross-linking Qa-2, the ped gene product, requires Fyn.
|
| |
Am J Reprod Immunol,
58,
315-324.
|
 |
|
|
|
|
 |
J.Yan,
V.V.Parekh,
Y.Mendez-Fernandez,
D.Olivares-Villagómez,
S.Dragovic,
T.Hill,
D.C.Roopenian,
S.Joyce,
and
L.Van Kaer
(2006).
In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.
|
| |
J Exp Med,
203,
647-659.
|
 |
|
|
|
|
 |
L.C.Sullivan,
H.L.Hoare,
J.McCluskey,
J.Rossjohn,
and
A.G.Brooks
(2006).
A structural perspective on MHC class Ib molecules in adaptive immunity.
|
| |
Trends Immunol,
27,
413-420.
|
 |
|
|
|
|
 |
R.Olson,
C.Dulac,
and
P.J.Bjorkman
(2006).
MHC homologs in the nervous system--they haven't lost their groove.
|
| |
Curr Opin Neurobiol,
16,
351-357.
|
 |
|
|
|
|
 |
J.R.Rodgers,
and
R.G.Cook
(2005).
MHC class Ib molecules bridge innate and acquired immunity.
|
| |
Nat Rev Immunol,
5,
459-471.
|
 |
|
|
|
|
 |
T.Leinders-Zufall,
P.Brennan,
P.Widmayer,
P.C.S,
A.Maul-Pavicic,
M.Jäger,
X.H.Li,
H.Breer,
F.Zufall,
and
T.Boehm
(2004).
MHC class I peptides as chemosensory signals in the vomeronasal organ.
|
| |
Science,
306,
1033-1037.
|
 |
|
|
|
|
 |
A.Ploss,
G.Lauvau,
B.Contos,
K.M.Kerksiek,
P.D.Guirnalda,
I.Leiner,
L.L.Lenz,
M.J.Bevan,
and
E.G.Pamer
(2003).
Promiscuity of MHC class Ib-restricted T cell responses.
|
| |
J Immunol,
171,
5948-5955.
|
 |
|
|
|
|
 |
P.Lau,
C.Amadou,
H.Brun,
V.Rouillon,
F.McLaren,
A.F.Le Rolle,
M.Graham,
G.W.Butcher,
and
E.Joly
(2003).
Characterisation of RT1-E2, a multigenic family of highly conserved rat non-classical MHC class I molecules initially identified in cells from immunoprivileged sites.
|
| |
BMC Immunol,
4,
7.
|
 |
|
|
|
|
 |
Y.Liu,
Y.Xiong,
O.V.Naidenko,
J.H.Liu,
R.Zhang,
A.Joachimiak,
M.Kronenberg,
H.Cheroutre,
E.L.Reinherz,
and
J.H.Wang
(2003).
The crystal structure of a TL/CD8alphaalpha complex at 2.1 A resolution: implications for modulation of T cell activation and memory.
|
| |
Immunity,
18,
205-215.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |